Clinical Trial Update: Post-marketing Surveillance to Assess the Safety of Boostrix Vaccine Given According to Prescribing Information in Korea

View source ↗

Summary

Post-marketing surveillance study assessing the safety of the Boostrix vaccine according to prescribing information in Korea has completed; results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Tetanus

Drugs mentioned

• Boostrix (Diphtheria, Tetanus, and Acellular Pertussis Vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diphtheria-Tetanus-acellular Pertussis Vaccines | Status: COMPLETED | Results posted: 2019-03-29